Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
Cardiol Therapeutics held its 2026 Annual General Meeting of Shareholders on June 24, where all management resolutions were approved by shareholders. The existing board of directors, including Dr. Guillermo Torre-Amione, David Elsley, and Chris Waddick, was re-elected with support ranging from 96% to 99% of votes cast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.